2664
CAWACHI LIMITED
株式会社カワチ薬品
Retail Trade
← Companies
⚠ TSE Capital Mandate
P / Book
0.63×
Financials
| Metric |
FY 2025
TDnet
|
FY 2024
EDINET ↗
|
FY 2023
EDINET ↗
|
FY 2022
EDINET ↗
|
FY 2021
EDINET ↗
|
| Net Sales |
¥284.5B
|
¥287.8B
|
¥286.0B
|
¥281.9B
|
¥279.5B
|
| Cost of Sales |
¥219.2B
|
¥221.1B
|
¥220.2B
|
¥217.8B
|
¥216.3B
|
| Gross Profit |
¥65.3B
|
¥66.7B
|
¥65.8B
|
¥64.0B
|
¥63.1B
|
| SG&A |
¥58.5B
|
¥59.3B
|
¥58.2B
|
¥57.4B
|
¥55.4B
|
| Operating Income |
¥6.8B
|
¥7.5B
|
¥7.6B
|
¥6.6B
|
¥7.7B
|
| Non-Operating Income |
¥1.6B
|
¥1.4B
|
¥1.5B
|
¥1.4B
|
¥1.4B
|
| Dividend Income |
—
|
¥3M
|
¥3M
|
¥2M
|
¥2M
|
| Interest Income |
—
|
¥17M
|
¥19M
|
¥21M
|
¥24M
|
| Non-Operating Expenses |
—
|
¥487M
|
¥452M
|
¥381M
|
¥409M
|
| Interest Expense |
—
|
¥36M
|
¥35M
|
¥41M
|
¥49M
|
| Ordinary Income |
¥7.9B
|
¥8.3B
|
¥8.6B
|
¥7.7B
|
¥8.7B
|
| Pre-tax Income |
¥5.6B
|
¥6.8B
|
¥7.2B
|
¥6.6B
|
¥7.7B
|
| Income Taxes |
¥2.4B
|
¥1.9B
|
¥2.4B
|
¥2.4B
|
¥2.9B
|
| Current Tax |
—
|
¥2.0B
|
¥2.4B
|
¥2.6B
|
¥2.9B
|
| Deferred Tax |
—
|
¥-80M
|
¥2M
|
¥-209M
|
¥-65M
|
| Net Income (owners) |
¥3.2B
|
¥4.9B
|
¥4.7B
|
¥4.2B
|
¥4.8B
|
| Comprehensive Income |
—
|
¥4.9B
|
¥4.7B
|
¥4.2B
|
¥4.8B
|
| EBITDA |
¥11.3B
|
¥12.0B
|
¥11.9B
|
¥11.0B
|
¥12.1B
|
| EPS |
¥143.30
|
¥218.72
|
¥211.03
|
¥187.06
|
¥216.44
|
| Shares Outstanding |
—
|
22.3M
|
22.3M
|
22.3M
|
22.3M
|
| Shares Issued (total) |
—
|
24.6M
|
24.6M
|
24.6M
|
24.6M
|
| Treasury Shares |
—
|
2.2M
|
2.2M
|
2.2M
|
2.3M
|
| Metric |
FY 2025
TDnet
|
FY 2024
EDINET ↗
|
FY 2023
EDINET ↗
|
FY 2022
EDINET ↗
|
FY 2021
EDINET ↗
|
| Total Assets |
¥199.6B
|
¥199.6B
|
¥196.1B
|
¥194.5B
|
¥191.7B
|
| Current Assets |
¥93.3B
|
¥90.5B
|
¥86.0B
|
¥83.5B
|
¥81.4B
|
| Cash & Deposits |
¥38.1B
|
¥36.7B
|
¥35.6B
|
¥38.5B
|
¥39.0B
|
| Trade Receivables |
—
|
¥14.7B
|
¥10.5B
|
¥6.6B
|
¥5.8B
|
| Inventories |
—
|
¥34.2B
|
¥34.7B
|
¥33.0B
|
¥31.4B
|
| Non-Current Assets |
¥106.3B
|
¥109.1B
|
¥110.1B
|
¥111.0B
|
¥110.3B
|
| PP&E |
¥89.7B
|
¥91.8B
|
¥92.5B
|
¥93.4B
|
¥92.9B
|
| Intangible Assets |
—
|
¥5.2B
|
¥5.4B
|
¥5.2B
|
¥5.1B
|
| Investment Securities |
¥306M
|
¥154M
|
¥129M
|
¥101M
|
¥79M
|
| Deferred Tax Assets |
—
|
¥4.3B
|
¥4.3B
|
¥4.3B
|
¥4.1B
|
| Total Liabilities |
¥83.7B
|
¥85.2B
|
¥84.8B
|
¥86.8B
|
¥87.1B
|
| Current Liabilities |
¥60.4B
|
¥60.9B
|
¥61.7B
|
¥62.4B
|
¥60.7B
|
| ST Debt |
¥5.7B
|
¥5.8B
|
¥6.7B
|
¥7.9B
|
¥9.2B
|
| Taxes Payable |
—
|
¥1.1B
|
¥1.4B
|
¥1.4B
|
¥1.2B
|
| Non-Current Liabilities |
¥23.3B
|
¥24.3B
|
¥23.1B
|
¥24.3B
|
¥26.4B
|
| Total LT Borrowings |
¥10.4B
|
¥10.8B
|
¥10.0B
|
¥11.6B
|
¥13.7B
|
| Pension Obligations |
—
|
¥9.3B
|
¥9.0B
|
¥8.7B
|
¥8.2B
|
| Total Equity |
¥115.9B
|
¥114.4B
|
¥111.3B
|
¥107.7B
|
¥104.6B
|
| Capital Stock |
—
|
¥13.0B
|
¥13.0B
|
¥13.0B
|
¥13.0B
|
| Capital Surplus |
—
|
¥14.9B
|
¥14.9B
|
¥14.9B
|
¥14.9B
|
| Retained Earnings |
¥92.2B
|
¥90.8B
|
¥87.7B
|
¥84.1B
|
¥81.0B
|
| Treasury Stock |
—
|
¥-4.4B
|
¥-4.4B
|
¥-4.4B
|
¥-4.4B
|
| AOCI |
—
|
¥51M
|
¥34M
|
¥15M
|
¥0M
|
| Equity (owners) |
¥115.7B
|
¥114.3B
|
¥111.2B
|
¥107.6B
|
¥104.5B
|
|
| Total Interest-Bearing Debt ⓘ |
¥16.1B
|
¥16.6B
|
¥16.7B
|
¥19.5B
|
¥22.9B
|
| Net Cash ⓘ |
¥22.0B
|
¥20.1B
|
¥18.9B
|
¥18.9B
|
¥16.0B
|
| NCAV ⓘ |
¥9.6B
|
¥5.3B
|
¥1.2B
|
¥-3.2B
|
¥-5.6B
|
| NCAV/Share |
—
|
¥236
|
¥53
|
¥-145
|
¥-253
|
| BV/Share |
—
|
¥5,118
|
¥4,979
|
¥4,818
|
¥4,683
|
| Metric |
FY 2025
TDnet
|
FY 2024
EDINET ↗
|
FY 2023
EDINET ↗
|
FY 2022
EDINET ↗
|
FY 2021
EDINET ↗
|
| Operating CF |
¥8.9B
|
¥7.5B
|
¥6.4B
|
¥9.8B
|
¥6.9B
|
| Interest Paid |
—
|
¥-37M
|
¥-34M
|
¥-42M
|
¥-49M
|
| Interest Received |
—
|
¥3M
|
¥3M
|
¥3M
|
¥3M
|
| D&A |
¥4.5B
|
¥4.5B
|
¥4.3B
|
¥4.3B
|
¥4.4B
|
| Investing CF |
¥-5.2B
|
¥-4.5B
|
¥-5.3B
|
¥-5.8B
|
¥-4.5B
|
| CapEx |
¥4.2B
|
¥4.1B
|
¥4.8B
|
¥5.3B
|
¥4.0B
|
| Financing CF |
¥-2.3B
|
¥-1.9B
|
¥-3.9B
|
¥-4.5B
|
¥-4.6B
|
| Dividends Paid |
—
|
¥-1.8B
|
¥-1.1B
|
¥-1.1B
|
¥-1.1B
|
| Share Buybacks |
—
|
—
|
¥0M
|
—
|
¥0M
|
| LT Debt Repaid |
—
|
¥-7.3B
|
¥-8.5B
|
¥-9.9B
|
¥-11.1B
|
| Free Cash Flow |
¥4.7B
|
¥3.4B
|
¥1.6B
|
¥4.6B
|
¥2.9B
|
| Net Change in Cash |
—
|
¥1.1B
|
¥-2.8B
|
¥-509M
|
¥-2.3B
|
| Metric |
FY 2025
TDnet
|
FY 2024
EDINET ↗
|
FY 2023
EDINET ↗
|
FY 2022
EDINET ↗
|
FY 2021
EDINET ↗
|
| ROE |
2.8%
|
4.3%
|
4.3%
|
3.9%
|
4.7%
|
| ROA |
1.6%
|
2.5%
|
2.4%
|
2.2%
|
2.5%
|
| EPS |
¥143.30
|
¥218.72
|
¥211.03
|
¥187.06
|
¥216.44
|
| DPS |
¥0.00
|
¥80.00
|
¥80.00
|
¥50.00
|
¥50.00
|
| BPS |
¥5,188.27
|
¥5,120.32
|
¥4,980.82
|
¥4,818.93
|
¥4,682.61
|
| FCF/Share |
—
|
¥152
|
¥70
|
¥204
|
¥130
|
| NCAV/Share |
—
|
¥236
|
¥53
|
¥-145
|
¥-253
|
| Payout Ratio |
0.0%
|
36.6%
|
37.9%
|
26.7%
|
23.1%
|
No filings or capital allocation signals recorded for this company.
| # |
Shareholder |
Shares (thou.) |
% of Total |
| 1 |
公益財団法人河内奨学財団
|
2,600
|
11.64%
|
| 2 |
河内 伸二
|
2,436
|
10.91%
|
| 3 |
河内 一真
|
2,287
|
10.24%
|
| 4 |
The Master Trust Bank of Japan, Ltd. (Trust Account)
日本マスタートラスト信託銀行株式会社(信託口)
|
1,744
|
7.81%
|
| 5 |
河内 博子
|
1,330
|
5.96%
|
| 6 |
河内 タカ
|
708
|
3.17%
|
| 7 |
Custody Bank of Japan, Ltd. (Trust Account)
株式会社日本カストディ銀行(信託口)
|
398
|
1.78%
|
| 8 |
カワチ薬品従業員持株会
|
322
|
1.44%
|
| 9 |
株式会社栃木銀行
|
200
|
0.90%
|
| 10 |
株式会社商工組合中央金庫
|
140
|
0.63%
|
Domestic Nominees
9.6%
+1.0% vs 2024
Trust bank custodians — GPIF, pensions, investment trusts
Foreign Custodians
0.0%
-0.7% vs 2024
Sub-custodians for foreign asset managers
Direct / Strategic
44.9%
+0.6% vs 2024
Named entities with disclosed investment intent
| Shareholder |
Trend |
2023
|
2024
|
2025
|
|
公益財団法人河内奨学財団
|
|
11.64%
|
11.64%
|
11.64%
|
|
河内 伸二
|
|
10.90%
|
10.90%
|
10.91%
+0.01%
|
|
河内 一真
|
|
10.24%
|
10.24%
|
10.24%
|
|
日本マスタートラスト信託銀行
|
|
7.02%
|
6.96%
|
7.81%
+0.85%
|
|
河内 博子
|
|
5.96%
|
5.96%
|
5.96%
|
|
河内 タカ
|
|
3.17%
|
3.17%
|
3.17%
|
|
日本カストディ銀行
|
|
1.42%
|
1.65%
|
1.78%
+0.13%
|
|
カワチ薬品従業員持株会
|
|
1.47%
|
1.49%
|
1.44%
-0.05%
|
|
式会社栃木銀行
NEW ENTRY
|
—
|
—
|
—
|
0.90%
NEW
|
|
式会社商工組合中央金庫
NEW ENTRY
|
—
|
—
|
—
|
0.63%
NEW
|
|
㈱栃木銀行
last seen 2024
|
Exited Top 10
|
0.90%
|
0.90%
|
—
|
|
State Street
last seen 2024
|
Exited Top 10
|
—
|
0.71%
|
—
|
|
Morgan Stanley
last seen 2023
|
Exited Top 10
|
1.00%
|
—
|
—
|
|
Concentration (HHI)
ⓘ
|
|
460
|
459
|
472
|
3 fiscal years · top-10 holders per year · >2,500 HHI = high concentration · entity-resolved
Portfolio Book Value
¥142M
+60% since 2023
Holdings
3
+2 new
2 exited
Trend
Stable
vs 2023
Book value in ¥M · ↓ reduced · ↑ increased vs prior year · M = mutual holding